Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2011 4
2012 4
2013 3
2014 3
2015 2
2016 3
2017 8
2018 5
2019 6
2020 6
2021 9
2022 6
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Infection-related seizure"
Page 1
Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
Hon KL, Leung AKC, Torres AR. Hon KL, et al. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):128-135. doi: 10.2174/1872213X12666180508122450. Recent Pat Inflamm Allergy Drug Discov. 2018. PMID: 29745347 Review.
METHODS: A Medline/Pubmed search was conducted using Clinical Queries with the key terms "Febrile Infection-Related Epilepsy Syndrome", "FIRES", "New-Onset Refractory Status Epilepticus" and "NORSE". The search strategy included meta-analyses, randomized …
METHODS: A Medline/Pubmed search was conducted using Clinical Queries with the key terms "Febrile Infection-Related Epi …
Status epilepticus: what's new for the intensivist.
Benghanem S, Robieux EP, Neligan A, Walker MC. Benghanem S, et al. Curr Opin Crit Care. 2024 Apr 1;30(2):131-141. doi: 10.1097/MCC.0000000000001137. Epub 2024 Feb 13. Curr Opin Crit Care. 2024. PMID: 38441162 Review.
Better understanding of the pathophysiology has indicated that nonanti-seizure medications aimed at underlying pathological processes should perhaps be considered in the treatment of SE; already immunosuppressant treatments are being more widely used in particular for new …
Better understanding of the pathophysiology has indicated that nonanti-seizure medications aimed at underlying pathological processes …
Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome.
Horino A, Kuki I, Inoue T, Nukui M, Okazaki S, Kawawaki H, Togawa M, Amo K, Ishikawa J, Ujiro A, Shiomi M, Sakuma H. Horino A, et al. Ann Clin Transl Neurol. 2021 Mar;8(3):645-655. doi: 10.1002/acn3.51308. Epub 2021 Feb 5. Ann Clin Transl Neurol. 2021. PMID: 33547757 Free PMC article.
OBJECTIVE: Increasing reports suggest a role for immunological mechanisms in febrile infection-related epilepsy syndrome (FIRES). The objective of this study was to elucidate the efficacy and safety of intrathecal dexamethasone therapy (IT-DEX). ...There was a posit …
OBJECTIVE: Increasing reports suggest a role for immunological mechanisms in febrile infection-related epilepsy syndrome (FIRE …
Rasmussen's syndrome treated with anakinra.
Arcan A, Kızılkılıç EK, Gündüz A, Unkun R, Vezzani A, Özkara Ç. Arcan A, et al. J Neurol. 2024 Feb;271(2):723-726. doi: 10.1007/s00415-023-12072-8. Epub 2023 Nov 3. J Neurol. 2024. PMID: 37922068
Anakinra, an IL-1 inhibitor, is successfully used in patients with new onset refractory status epilepticus and febrile infection-related epilepsy syndrome. METHODS AND RESULTS: We present 38-year-old male with RE having right-sided hemiparesis and continuous spasms …
Anakinra, an IL-1 inhibitor, is successfully used in patients with new onset refractory status epilepticus and febrile infection-r …
Neurocritical care and target immunotherapy for febrile infection-related epilepsy syndrome.
Sakuma H, Horino A, Kuki I. Sakuma H, et al. Biomed J. 2020 Jun;43(3):205-210. doi: 10.1016/j.bj.2020.03.009. Epub 2020 Apr 21. Biomed J. 2020. PMID: 32330681 Free PMC article. Review.
Febrile infection-related epilepsy syndrome (FIRES) is an intractable neurological disease characterized by an unexplained refractory status epilepticus triggered by febrile infection. ...The basic approach to the management of FIRES, like other forms of epilepsy, i …
Febrile infection-related epilepsy syndrome (FIRES) is an intractable neurological disease characterized by an unexplained ref …
Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A, Muscal E, Hirsch LJ. Hanin A, et al. Epilepsia. 2024 May;65(5):1203-1223. doi: 10.1111/epi.17933. Epub 2024 Mar 2. Epilepsia. 2024. PMID: 38430119 Review.
Several pieces of evidence suggest immune dysregulation could trigger the onset and modulate sequelae of new onset refractory status epilepticus (NORSE), including its subtype with prior fever known as febrile infection-related epilepsy syndrome (FIRES). Consensus-d …
Several pieces of evidence suggest immune dysregulation could trigger the onset and modulate sequelae of new onset refractory status epilept …
Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease.
Tan TH, Perucca P, O'Brien TJ, Kwan P, Monif M. Tan TH, et al. Epilepsia. 2021 Feb;62(2):303-324. doi: 10.1111/epi.16788. Epub 2020 Dec 14. Epilepsia. 2021. PMID: 33316111 Review.
Pathogenic antibodies, complement activation, CD8+ cytotoxic T cells, and microglial activation are seen, to various degrees, in different seizure-associated neuroinflammatory and autoimmune conditions. These aberrant immune responses are thought to cause disruptions in ne …
Pathogenic antibodies, complement activation, CD8+ cytotoxic T cells, and microglial activation are seen, to various degrees, in different …
Antiepileptic drugs for the primary and secondary prevention of seizures after stroke.
Chang RS, Leung WC, Vassallo M, Sykes L, Battersby Wood E, Kwan J. Chang RS, et al. Cochrane Database Syst Rev. 2022 Feb 7;2(2):CD005398. doi: 10.1002/14651858.CD005398.pub4. Cochrane Database Syst Rev. 2022. PMID: 35129214 Free PMC article. Review.
BACKGROUND: Seizures after stroke are an important clinical problem and may result in poor outcomes. ...The first study was a randomised double-blind study comparing valproic acid with placebo for primary seizure prevention up to one year after stroke. …
BACKGROUND: Seizures after stroke are an important clinical problem and may result in poor outcomes. ...The first study was a …
Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES).
Fetta A, Crotti E, Campostrini E, Bergonzini L, Cesaroni CA, Conti F, Di Pisa V, Gentile V, Mondardini MC, Vezzoli C, Giordano L, Cordelli DM. Fetta A, et al. Epilepsia Open. 2023 Jun;8(2):685-691. doi: 10.1002/epi4.12740. Epub 2023 Apr 24. Epilepsia Open. 2023. PMID: 37042946 Free PMC article.
Febrile infection-related epilepsy syndrome (FIRES) is a prolonged refractory status epilepticus (SE) that develops among healthy individuals after a febrile infection. ...SE resolved within 3 days of reaching the target dose and both were seizure-free for 1 …
Febrile infection-related epilepsy syndrome (FIRES) is a prolonged refractory status epilepticus (SE) that develops among heal …
Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A, Hariramani R, Gonzalez-Martinez A, Álvarez-Troncoso J, Toledano R, Bayat A, Garcia-Morales I, Becerra JL, Villegas-Martínez I, Beltran-Corbellini A, Gil-Nagel A. Aledo-Serrano A, et al. Seizure. 2022 Aug;100:51-55. doi: 10.1016/j.seizure.2022.06.012. Epub 2022 Jun 22. Seizure. 2022. PMID: 35759951 Free article.
PURPOSE: There is scarce evidence of effective treatments for the chronic phase of Febrile infection-related epilepsy syndrome (FIRES). This study aimed to analyze the outcomes of treatment with anakinra and tocilizumab. ...Median treatment duration was 9months (IQR …
PURPOSE: There is scarce evidence of effective treatments for the chronic phase of Febrile infection-related epilepsy syndrome …
56 results